These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Decreased CD14+CCR2+ monocytes in active multiple sclerosis. Nakajima H; Sugino M; Kimura F; Hanafusa T; Ikemoto T; Shimizu A Neurosci Lett; 2004 Jun; 363(2):187-9. PubMed ID: 15172112 [TBL] [Abstract][Full Text] [Related]
9. MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis. Peterson KE; Errett JS; Wei T; Dimcheff DE; Ransohoff R; Kuziel WA; Evans L; Chesebro B J Virol; 2004 Jun; 78(12):6449-58. PubMed ID: 15163738 [TBL] [Abstract][Full Text] [Related]
10. Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases. Bose S; Cho J Arch Pharm Res; 2013 Sep; 36(9):1039-50. PubMed ID: 23771498 [TBL] [Abstract][Full Text] [Related]
14. Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and the chemokine receptor CCR2 by purified human blood monocytes. Møller AS; Øvstebø R; Westvik AB; Joø GB; Haug KB; Kierulf P J Endotoxin Res; 2003; 9(6):349-60. PubMed ID: 14733721 [TBL] [Abstract][Full Text] [Related]
15. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Tanuma N; Sakuma H; Sasaki A; Matsumoto Y Acta Neuropathol; 2006 Aug; 112(2):195-204. PubMed ID: 16733654 [TBL] [Abstract][Full Text] [Related]
17. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472 [TBL] [Abstract][Full Text] [Related]
18. Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barré syndrome and experimental autoimmune neuritis. Orlikowski D; Chazaud B; Plonquet A; Poron F; Sharshar T; Maison P; Raphaël JC; Gherardi RK; Créange A J Neuroimmunol; 2003 Jan; 134(1-2):118-27. PubMed ID: 12507779 [TBL] [Abstract][Full Text] [Related]
19. Recent developments in CCR2 antagonists. Xia M; Sui Z Expert Opin Ther Pat; 2009 Mar; 19(3):295-303. PubMed ID: 19441905 [TBL] [Abstract][Full Text] [Related]